-
Genprex doses first subject in expansion part of lung cancer gene therapy trial
24 Jan 2025 20:59 GMT
… the Reqorsa gene therapy (quaratusugene ozeplasmid) for extensive-stage small-cell lung cancer (ES … -SCLC) patients.
The trial will assess the gene therapy as … the Acclaim-3 subjects. The gene therapy has also been granted orphan …
-
Genprex starts patient dosing in phase 2 expansion portion of Acclaim─3 study of Reqorsa Gene Therapy in combo with Tecentriq to treat SCLC
24 Jan 2025 13:17 GMT
… Inc., a clinical-stage gene therapy company focused on developing … clinical study of Reqorsa Gene Therapy (quaratusugene ozeplasmid) in … extensive stage small cell lung cancer (ES-SCLC).
“We … drug candidate, Reqorsa Gene Therapy, in combination with Genentech …
-
Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More
24 Jan 2025 06:25 GMT
… of gene therapy developer Audentes Therapeutics. Within gene therapy, the … brought AT132, a gene therapy for the rare … gene therapy, Taniguci said. The company is already developing gene therapies … and non-small cell lung cancers. Taniguci noted the …
-
Non-Small Cell Lung Cancer Pipeline, Clinical Trials, Emerging Drugs Approvals and Companies | DelveInsight
22 Jan 2025 10:41 GMT
… Small Cell Lung Cancer Clinical Trials Assessment
Non-Small-Cell Lung cancer (NSCLC … cell lung cancer.
Learn more about Non-Small Cell Lung Cancer Drugs …
• Gene therapy
Discover the latest advancements in Non-Small Cell Lung Cancer Treatment …
-
Effects of Tp53 Gene Mutations on the Survival of Non-Small Cell Lung Cancer (NSCLC); A Short Review
15 Jan 2025 11:59 GMT
… lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer … TP53 gene-therapy also investigated in clinical-trials in lung-cancer … non-small cell lung cancers. Lung Cancer. 2016;99:102 … non-small-cell lung cancer. Lung Cancer. 2018;123:22 …
-
Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom As Over 100 Companies Leading The Charge In Research And Development Delveinsight
14 Jan 2025 23:45 GMT
… The classification of lung tumors is based on … , Peptide, Polymer, Gene therapy
Therapeutics Assessment
By Mechanism … Small Cell Lung Cancer Market
Small Cell Lung Cancer Market Insights, …
Small-cell Lung Cancer Pipeline
Small-cell Lung Cancer Pipeline Insight …
-
70 chief strategy officers to know | 2024
08 Feb 2025 02:47 GMT
… the $100 million cell and gene therapies initiative, aimed at advancing disease … ’s leadership in cell and gene therapy. Through this work, faculty at … a pivotal force in advancing lung cancer care and outcomes. As chair …
-
Unveiling the Dark Genome: Targeting Stress-Activated Base Editors to Halt Cancer Progression
07 Feb 2025 23:53 GMT
… see this in patients with lung cancer and breast cancer, and these … cancer treatment: stem cell and gene therapy breakthroughs. Presented at: Precision Medicine …
-
AdvanCell Completes $112 Million Oversubscribed Series C Financing
07 Feb 2025 22:25 GMT
… accessible, custom-tailored gene therapy solution for treating hereditary … advanced non-small cell lung cancer, Lazcluze (lazertinib) in … ) for treatment of lung cancer patients in England and … NICE Recommendations for Lung Cancer Patients Across England …
-
Advancing Gene Therapy: Enzyme Selection for Effective RNA Oligonucleotide Mapping
03 Jan 2025 22:17 GMT
New gene therapy modalities, such as CRISPR guide … , PIK3CA and BRAF in Clinical Lung Tumors. Clin. Lab. 2016, 62 (04 …
About
© 1995-2025